Geron (GERN) Receivables (2015 - 2026)
Geron (GERN) posted Receivables of $44.1 million for Q1 2026, up 12.41% sequentially from $39.2 million in Q4 2025, and up 29.76% YoY from $34.0 million in Q1 2025.
Geron (GERN) Receivables (2015 - 2026) Analysis & Trends
Geron has reported Receivables for 5 years, with the latest figure at $44.1 million in Q1 2026.
- Quarterly Receivables rose 29.76% year-over-year to $44.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $44.1 million (up 29.76% YoY) and the FY2025 annual result came in at $39.2 million, up 1.1% from the prior year.
- Receivables rose to $44.1 million in Q1 2026 per GERN's latest filing, from $39.2 million in the prior quarter.
- Over five years, Receivables peaked at $44.1 million in Q1 2026 and troughed at $3.1 million in Q2 2024.
- A 3-year average of $33.3 million and a median of $38.2 million in 2024 frame the typical range for Receivables.
- The widest YoY moves for Receivables: up 1159.21% in 2025, down 1.1% in 2025.
- Over 3 years, Receivables stood at $38.8 million in 2024, then gained by 1.1% to $39.2 million in 2025, then grew by 12.41% to $44.1 million in 2026.
- According to Business Quant data, Receivables over the past three periods registered $44.1 million, $39.2 million, and $37.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.23 Bn | 132.38 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 86.97 Bn | 78.97 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 59.88 Bn | 54.74 Bn | 52.00 Mn | 160.00 Mn |
| 5 | BeOne Medicines | 42.20 Bn | 37.11 Bn | 1.53 Bn | 1.06 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | 912.74 Mn |
| 7 | BioNTech SE | 28.69 Bn | 10.30 Bn | 668.28 Mn | 1.09 Bn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | 215.33 Mn |
| 9 | Royalty Pharma | 27.16 Bn | 26.33 Bn | - | - |
| 10 | Geron | 1.05 Mn | -299.80 Mn | - | 53.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 53.50 Mn |
| Mar 31, 2026 | 44.10 Mn |
| Dec 31, 2025 | 39.23 Mn |
| Sep 30, 2025 | 37.66 Mn |
| Jun 30, 2025 | 39.36 Mn |
| Mar 31, 2025 | 33.98 Mn |
| Dec 31, 2024 | 38.80 Mn |
| Sep 30, 2024 | 30.09 Mn |
| Jun 30, 2024 | 3.13 Mn |
| Sep 30, 2016 | 5.40 Mn |
| Dec 31, 2015 | 2.41 Mn |